Nf1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| NF1 Protein | |
|---|---|
| Protein Name | Neurofibromin 1 |
| Gene | NF1 |
| UniProt ID | P21359 |
| PDB ID | 3GC8, 3PED |
| Molecular Weight | 327 kDa (2818 aa) |
| Subcellular Localization | Cytoplasm, Membrane-associated |
| Protein Family | Ras GTPase-activating protein family |
NF1 (Neurofibromin 1) is a protein encoded by a gene located on chromosome 17q11.2. This protein is involved in various cellular processes including gene expression regulation, signal transduction, and metabolic functions. NF1 plays important roles in neuronal function and is implicated in neurodegenerative diseases.
NF1 is one of the largest proteins encoded by a single gene. The key functional domain is the GAP-related domain (GRD):
The GRD shares homology with p120GAP and is the primary tumor suppressor activity.
NF1 functions as a tumor suppressor by negatively regulating Ras signaling:
In neurons:
| Approach | Drug/Agent | Status | Mechanism |
|---|---|---|---|
| MEK inhibitors | Selumetinib, Trametinib | FDA approved (NF1) | Block Ras downstream |
| mTOR inhibitors | Everolimus | Clinical | Block dysregulated growth |
| Statins | Simvastatin | Clinical | Reduce Ras prenylation |
| cAMP modulators | PDE inhibitors | Preclinical | Improve cognition |
| Farnesyltransferase inhibitors | Tipifarnib | Preclinical | Block Ras modification |
The study of Nf1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.